Trial site
RE:Cognition (Chicago)
- 3running trials
- 0closed trials
- 0trials confirmed by the site in the last 60 days
- –languages not stated
The site has not confirmed any trial yet.
Running trials
Active, not recruiting
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
Active, not recruiting
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
Researchers
No researcher is linked here yet.
Site data: ClinicalTrials.govUpdated 5 Nov 2026